JENNIFER FOSTER to Antibodies, Monoclonal
This is a "connection" page, showing publications JENNIFER FOSTER has written about Antibodies, Monoclonal.
Connection Strength
0.792
-
The safety of dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma. Expert Opin Drug Saf. 2018 Dec; 17(12):1257-1262.
Score: 0.377
-
Dinutuximab for the treatment of pediatric patients with neuroblastoma. Drugs Today (Barc). 2017 Sep; 53(9):469-476.
Score: 0.346
-
Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study. Pediatr Blood Cancer. 2026 May; 73(5):e70195.
Score: 0.039
-
Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor. J Clin Oncol. 2023 01 20; 41(3):508-516.
Score: 0.031